Our Japanese company manufactures and commercialises Ursodeoxycholic acid (UDCA) for local and export markets.
Our Indian company manufactures and commercialises Ursodeoxycholic acid (UDCA) for the local market.
ABC develops and manufactures products for the pharmaceutical, nutraceutical and cosmetics markets, and provides CDMO services.
Our New Zealand company produces pharma grade cholic acid and exports a range of bile acid derivatives.
Our UK company specialises in carbohydrate chemistry providing products for R&D and contract manufacturing services.
Our company
An unmatched experience and expertise
With over 70 years of experience and 1500 world-wide employees, ICE Pharma provides both products and services to the pharmaceutical industry.
ICE Pharma is an expert in the development and manufacture of bile acid derivatives. We are a leading producer of Ursodeoxycholic Acid (UDCA) with an integrated global manufacturing network in Europe, Latin America, Asia and Oceania that serves customers in over 50 countries.
Our five R&D centres have enabled us to develop a unique and comprehensive range products including Generic APIs, Excipients, Finished Dosage Forms and New Chemical Entities.
Our Products & Services
We offer a comprehensive & unique range of products & services
Learn more
Pharmaceutical
We offer an extensive range of products for the pharmaceutical market including APIs, Finished Dosage Forms and Excipients.
CDMO Services
We provide pharmaceutical contract development and manufacturing services for solid and liquid finished dosage forms and complex carbohydrates
Nutraceutical
Our range of branded nutraceutical supplements is focused on strengthening the immune system and gut health. We are also a provider of natural taurine.
Research Chemicals
We supply the academic and research communities with complex carbohydrates and novel bile acid derivatives.
Our global footprint
Facilities & companies across the globe
ICE Pharma has an interconnected network of 7 manufacturing facilities in North and South America, Europe, Asia and Oceania through which we provide our customers with an unparalleled security of supply and a local service.
News & Articles
Stay up to date with ICE Pharma’s latest news, events & publications
ICE Pharma Sites in Basaluzzo and Reggio Emilia Obtain Authorized Economic Operator (AEO) Status
ICE Pharma is pleased to announce that its Basaluzzo and Reggio Emilia sites have successfully obtained Authorized Economic Operator (AEO) status from the Italian Customs and Monopolies Agency (Agenzia...
Raichem Strengthens Community Support in Raichur with Clean Water and Food Initiatives
Reinforcing its commitment to corporate social responsibility and community welfare, Raichem has launched two impactful initiatives in Raichur, Karnataka, addressing critical challenges related to access to clean drinking water...
Corporate Social Responsibility in the Pharmaceutical Industry: Advancing Global Health Through Sustainable Impact
In the evolving landscape of the B2B pharmaceutical industry, companies are expected to deliver more than high-quality products and services. Today, corporate social responsibility (CSR) and ESG in pharma...
